Yuanlong Z. Li
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Corrigendum to "The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma" [Translational Oncology 22 (2022) 101463].
Journal: Translational oncology
Published: June 17, 2026
Effect of MALT1 inhibition by MI‑2 on the microglial phenotype switch, inflammatory cytokine secretion, neuronal loss and oxidative stress in Alzheimer's disease.
Journal: International journal of molecular medicine
Published: January 06, 2026
CDGSH Iron Sulfur Domain 1 Relieves Neuronal Ferroptosis via Activating AMPK Pathway in Alzheimer's Disease.
Journal: Molecular neurobiology
Published: December 12, 2025
RRBP1 Inhibition Reduces Microglial M1 Polarization and Inflammation-Mediated Neuronal Loss and Oxidative Stress by Regulating ERK Pathway in Alzheimer's Disease.
Journal: Molecular neurobiology
Published: July 02, 2025
Multicenter evaluation of the diagnostic efficacy of jaundice color card for neonatal hyperbilirubinemia
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: May 19, 2024
Long Non-Coding RNA MALAT1 Protects Against Spinal Cord Injury via Suppressing microRNA-125b-5p Mediated Microglial M1 Polarization, Neuroinflammation, and Neural Apoptosis.
Journal: Molecular neurobiology
Published: June 26, 2023
Targeting lncRNA NEAT1 Hampers Alzheimer's Disease Progression.
Journal: Neuroscience
Published: October 19, 2022
The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma.
Journal: Translational oncology
Published: March 03, 2022
Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
Journal: Neuroscience letters
Published: November 11, 2021
Detection of sivelestat and its metabolite in small volumes of plasma from Chinese ALI/ARDS patients with SIRS via high-throughput UPLC-MS/MS: A pharmacokinetic study.
Journal: Journal of pharmaceutical and biomedical analysis
Published: August 10, 2020
Last Updated: 09/26/2026